2026-03-18 08:00
46% growth with strong momentum in the USA and for Pharma Services Q3 (Nov 2025–Jan 2026) (comparison figures are for the same period 2024/2025) Q1–Q3 (May 2025–Jan2026) (comparison figures are for the same period 2024/2025) Significant...
2025-12-18 08:30
Positioned for growth in Pharma Services and in the USA Q2 (August– October 2025) (comparison figures same period 2024) Q1 and Q2 (May – October 2025) (comparison figures same period 2024) Significant events during Q2 (August – October...
2025-09-11 08:00
Partnership agreement with Tempus and continued organic growth in the USA Biovica in brief – Treatment decisions with greater certainty FNCA Sweden AB is the company’s Certified Adviser. For more information, please visit: www.biovica.com...
2025-06-18 08:00
Positive development in the USA continues Biovica in brief – Treatment decisions with greater certainty Webcast:When: 18 June 2025, 3 PM to 4 PM CETWhere: register via: https://www.eventbrite.com/e/biovica-q4-earnings-call-2024-25-tickets-1392516366939Broadcast...
2025-03-13 08:00
Quarterly sales doubled, expanding market potential exponentially Significant events during the third quarter Significant events after the end of the period Webcast:When: 13/3 2025 kl. 15.00 CETWhere: registration via: Biovica Q3 Report FY 2024/2025Broadcast...
2024-12-12 08:00
Significant events during the second quarter Significant events after the end of the period Webcast:When: 12/12 2024 kl. 15.00 CETWhere: registration via: Biovica Q2 Earnings Call, Thu, Dec 12, 2024 at 3 PM CETBroadcast language: in English CEO’s...
2024-09-12 10:25
Correction due to missing MAR-legend Significantly increased sales in the USA and much improved cash flow Significant events during the first quarter Significant events after the end of the period Webcast:When: 12 September 2024, 3 PM to 4 PM CETWhere...
2024-09-12 08:00
Significantly increased sales in the USA and much improved cash flow Significant events during the first quarter Significant events after the end of the period Webcast:When: 12 September 2024, 3 PM to 4 PM CETWhere: registration via: Biovica Q1 Earnings...
2024-06-18 08:00
Steadily increasing sales in the USA Significant events during the first three quarters Significant events during the fourth quarter Significant events after the end of the period Webcast:When: 18 June 2024, 3 PM to 4 PM CETWhere: registration via lyyti...
2024-03-14 08:00
Several new commercial agreements signed and evidence that DiviTum® TKa significantly improves clinical routines in the USA. Significant events during the third quarter Significant events after the end of the period Webcast:When: 14/3 2024 kl. 15.00...
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects